Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19
- PMID: 33645482
- DOI: 10.2174/1567201818666210301102320
Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19
Abstract
Objective: The outbreak of COVID-19 caused by SARS-CoV-2 has promptly spread worldwide. This study aimed to predict mature miRNA sequences in the SARS-CoV-2 genome, their effects on protein-protein interactions in the affected cells, and gene-drug relationships to detect possible drug candidates.
Methods: Viral hairpin structure prediction, classification of hairpins, mutational examination of precursor miRNA candidate sequences, Minimum Free Energy (MFE) and regional entropy analysis, mature miRNA sequences, target gene prediction, gene ontology enrichment, and Protein-Protein Interaction (PPI) analysis, and gene-drug interactions were performed.
Results: A total of 62 candidate hairpins were detected by VMir analysis. Three hairpin structures were classified as true precursor miRNAs by miRBoost. Five different mutations were detected in precursor miRNA sequences in 100 SARS-CoV-2 viral genomes. Mutations slightly elevated MFE values and entropy in precursor miRNAs. Gene ontology terms associated with fibrotic pathways and immune system were found to be enriched in PANTHER, KEGG and Wiki pathway analysis. PPI analysis showed a network between 60 genes. CytoHubba analysis showed SMAD1 as a hub gene in the network. The targets of the predicted miRNAs, FAM214A, PPM1E, NUFIP2 and FAT4, were downregulated in SARS-CoV-2 infected A549 cells.
Conclusion: miRNAs in the SARS-CoV-2 virus genome may contribute to the emergence of the Covid-19 infection by activating pathways associated with fibrosis in the cells infected by the virus and modulating the innate immune system. The hub protein between these pathways may be the SMAD1, which has an effective role in TGF signal transduction.
Keywords: Covid-19; SARS-CoV-2; SMAD1; in silico; miRNA; pandemic..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.Comput Biol Med. 2021 Jul;134:104451. doi: 10.1016/j.compbiomed.2021.104451. Epub 2021 Apr 27. Comput Biol Med. 2021. PMID: 34020131 Free PMC article.
-
An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.Comput Biol Chem. 2020 Oct;88:107352. doi: 10.1016/j.compbiolchem.2020.107352. Epub 2020 Aug 1. Comput Biol Chem. 2020. PMID: 32771962 Free PMC article.
-
Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.BMC Biotechnol. 2021 Mar 12;21(1):22. doi: 10.1186/s12896-021-00680-z. BMC Biotechnol. 2021. PMID: 33711981 Free PMC article.
-
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1. Infect Genet Evol. 2021. PMID: 33812037 Free PMC article.
-
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21. J Infect Public Health. 2022. PMID: 35751930 Free PMC article. Review.
Cited by
-
Noncoding RNA therapeutics - challenges and potential solutions.Nat Rev Drug Discov. 2021 Aug;20(8):629-651. doi: 10.1038/s41573-021-00219-z. Epub 2021 Jun 18. Nat Rev Drug Discov. 2021. PMID: 34145432 Free PMC article. Review.
-
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review.Life (Basel). 2022 Feb 15;12(2):288. doi: 10.3390/life12020288. Life (Basel). 2022. PMID: 35207576 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous